light microscopy reveal bridge bone vertebral body 75 68 specimen ht treat spine none treatment p 0.021 fig 3 table 2. compare nonoperated l34 l6s1 level operate level show anterior endplate osteophyte extend past anterior fiber af 1424 specimenlevels 58 18 12.5 lacz 58 62.5 hm 88 100 ht p 0.0042 lacz versus ht pairwise comparison significant medullary space ht fusion bone continuity intramedullary canal vertebral body suggestive extensive fusion callous remodel marrow space induce fusion bone note extensive fatty infiltration fig 3d h. obvious bone formation observe within af lamella fuse level bone present ivd interior consistent evidence vascular marrow element within disc space apposition endplate needle puncture site alcian blue stain np preserve treatment fig 3eh suggestion disc height loss kyphosis across disc space note httreated fuse level fig 3 4a presume due fusion tether anteriorly continue growth epiphysis alcian blue cartilageappearing cell note anterior longitudinal ligament anterior af lamella contiguous juxtapose cartilaginous growth plate observe lacz hm ht treatment group fig 3fh cartilage cleave note ht bridge fusion specimen fig 4 also contiguous cartilaginous growth plate think represent cell describe anterior af note treatment group disorganization fiber annulus fibrosis cartilage endplate note surgical specimen specific treatment condition also loss np biphasic alcian blue stain physaliphorous cell general increase np cell number example np cell clone study describe rat model proof concept percutaneous anterior spine fusion human knowledge report first reproducible anterior spine fusion comparative animal model without extensive damage partial mechanical removal ivd intradiscal injection bone marrowderived stromal cell genetically modify express bmp27 ht result increase spinal stiffness successful spinal fusion one level 94 1516 treat animal abundant bone formation anterior lateral ivd differential osteoinduction demonstrate little bone formation spine fusion lacz negative control bone formation consistent fusion delivery bmp2 bmp7 homodimers alone combination bone fusion note ht treatment fusion bone remodel marrow cavity continuous host vertebral body notably despite concept use af anatomical containment ivd treatment delivery bone induction bone present ivd space find fusion bone formation occur consistently bmp27 ht group agreement previous find bmp heterodimers know potent osteoinductive factor certain set even express lower level homodimer counterpart superosteoinductive capacity heterodimers may due ability escape sequestration noggin induce le inflammation homodimer bmps alter use specific cell surface receptor drive different intracellular signal pathway previously report successful posterior spine fusion use adbmp7 bone allograft separately use adnull adbmp2 adbmp7 combine adbmp2adbmp7 bone allograft best fusion result obtain deliver treatment capable generate bmp27 heterodimers however intradiscal delivery model successful fusion achieve bmp27 ht group suggest anterior fusion model may require stronger osteoinductive presence success bmp heterodimer osteoinduction mechanism require investigation strike find resistance ivd bmpinduced fusion bone impressive ivdnp preservation irrespective treatment although trace fusion bone may form anteriormost af lamella deeper af np suggestion bone formation significant bone produce exposure zone anterior anterolateral spine consistent prior ivd bmp study despite previous report clinical animal study bone induce far anterior involve vascular visceral organ none laterally involve lumbar nerve root posteriorly compromise spinal canal several mechanism could explain induction fusion bone induce restrict location 1 damage soft tissue exposure zone osteoprogenitor cell respond osteoinductive signal reside 2 implant bmpexpressing cell may leak ivd fusion location 3 inner portion ivd avascular allow bone inductionformation 4 apart vascularity ivd act barrier neoosteogenesis either production signal specific proteoglycans extracellular matrix cell membrane glypicans lesswell characterize directactive antiosteogenesis signal mechanism combination thereof best explain fusion bone localization require future investigation possibly deliver traceable geneexpressing cell gene drive neoangiogenesis ivd vascular endothelial growth factor enzyme degrade ivd matrix andor disrupt np signal observe preservation np compartment disc help explain induce fusion bone exclude ivd raise question regard disc remain nearly normal endplate perforation anticipate result rapid ivd degeneration potentially fusion neither observe 12 week disc preservation lacz genecelldelivery suggest bmpdependent disc preservation mechanism absence ivd degeneration ossification may reflect lack bipedal spine load study duration short possibly application bone marrow stromal cell regardless genetic modification although mechanism ivd preservation andor exclusion bone formation disc space define study conclude npivd block intervertebral bone formation fusion within ivd major strength study use intermittent niad assessment allow u measure relative kinetics spinal stiffen occur course study without require euthanasia large number animal time point method limit number animal require study spine fusion need final assessment plus others require histological assessment time course 12 week niad correlate significantly ivad formal biomechanics endpoint ivad q supplementary fig s2 directly relate bend stiffness ei equation 12 df x yei report base geometry f 12 q tanf da 05 outer support distance error introduce interpret identically equation measure adjustment creep correct creep however adjust scalar add 06f average error equate ivad ei reduce 30 extension error magnitude would require experimental treatment effect large enough exceed error ivad similar approach successfully use muschik et al 2000 experimentallyfused spinal segment immobilize one end load specify flexion extension load end induce radiographic vertebral body alignment change measure interpret objective endpoint reflect relative stiffness niad ivad assessment simple perform offer objective measurement relative induce spinal stiffness niad use nonlethal method follow relative spinal stiffness small animal course experiment another strength study multimodal fusion assessment prior description ivd fusion model nonuniformly use multiple fusion endpoint assessment clinically fusion gold standard surgical exploration mechanical load segment question radiographic criteriabased method consider prone falsepositive false negative error comparative model palpation also gold standard despite potential subjectivity unblinded raters use objective mechanical test force apply specimen deflection stiffness measure commonly report ivd fusion study lead false positive radiographichistology fusion illustrate point fig 4 lateral highdefinition xrays animal cod moderate greater bone production correlate palpation dichotomous radiographic fusion status midsagittal microct cut animal undergo microct fusion many image demonstrate considerable induce fusion bone palpation rat fuse sample sample residual motion detectable employ blind 3rater palpation assessment fusion decide majority effort minimize interrater influence decrease potential single rater systematically skew result individual rat style fourpoint bend test examine specimen objectively possible several limitation exist study track cell implant comment viability time location time gene expression ex vivo genetherapy method also permit control quantification level duration gene expression lack uniform statistical significance ht group attribute infrequency stiff 2level fusion subsequent effect treatment group interquartile range error estimate furthermore achieve doublelevel fusion ht group would strengthen several correlation report might enable use parametric statistic power study ass fusion palpation use majority sample destructive biomechanical test sample histology microct intermediate time 4 8 week may elucidate process bone formation model additional histology microct sample 12 week include sample treatment group may identify anterior af lamella cartilage cleave present fusion mass involve produce fusion bone describe proof concept work progress towards design percutaneousminimallyinvasive technique human anterior spine fusion exact technique implement today would major concern include requirement large openmaximallyinvasive anterior approach iatrogenic kyphogenesis treat level potentially different efficacy leakage treatment deliver degenerate disc likely clinical target treatment regard approach efficient percutaneous access two disc rodent number time require study would extremely challenge however percutaneously access disc human well describe utilize instead open technique furthermore important sagittal plane show spinal surgery fusion technique drive undesired kyphosis would big problem suggest kyphosis encounter model cause differential lack anterior growth mediate fusion tether cause growth arrest preserve posterior growth disc complex epiphysisdiscepiphysis similar posterior tether anterior overgrowth mechanism use explain crankshaft phenomenon young child spine fusion would seem kyphogenesis would concern population patient still grow child adolescent would avoidable able use technique older patient refine model engineer bone growth inside disc space fuse epiphysis epiphysis originally intend regard use technique degenerate instead normal disc easier get method work set degeneration describe antiosteogenic np cell would le populous degenerate tissue weaken interference induce mineralization bone formation previously report cell leak disc inject leakage appear result observable generation heterotopic bone assess highdefinition ap lateral xrays use study study potential effect treatment leakage implantation site warrant use intradiscal gene delivery reproducible lumbar spine fusion achieve bmp27 heterodimers treatment result demonstrate manual palpation fusion radiographic measure also three objective measure spine stiffness histology also describe nonlethal method niad monitor spine stiffness small animal spine fusion study time course bone induce bmp27 treatment locate outside disc space suggest disc matrix cell either inert physical barrier active inhibitor bone production within ivd observation support possibility develop method percutaneous human anterior spine fusion future investigation must address engineer osteoinduction within ivd assess feasibility allogeneic cell implantation evaluate success technique larger comparative \<SEP>4